It is used for the quantitative determination of the residual white blood cell (
It is used for the quantitative determination of the residual white blood cell (leukocyte) count in a human specimen using ADAM-rWBC HT.
The ADAM-rWBC HT residual leukocyte counter is a designed for counting residual
The ADAM-rWBC HT residual leukocyte counter is a designed for counting residual white blood cells (rWBCs) in leukoreduced blood products.
ADAMII-CD34 Kit is designed for use with the ADAMII instrument, benchtop image-b
ADAMII-CD34 Kit is designed for use with the ADAMII instrument, benchtop image-based fluorescence cell counter.ADAMII-CD34 Kit provides the percentages of total and viable cells that are CD34+(%CD34).
ADAMII is a device to count stained CD series (e.g. CD34, CD3, CD4, CD8, CD45, e
ADAMII is a device to count stained CD series (e.g. CD34, CD3, CD4, CD8, CD45, etc.) in human sample as an aid in the management of patients.
ADAM-rWBC2 System is composted ADAM-rWBC2(equipment) and ADAM-rWBC Kit (reagent)
ADAM-rWBC2 System is composted ADAM-rWBC2(equipment) and ADAM-rWBC Kit (reagent). This system is intended to be used for the qualitative determination of the residual white blood cell (leukocyte) count in the human specimen.
ADAM-rWBC System is composted ADAM-rWBC(equipment) and ADAM-rWBC kit (reagent).
ADAM-rWBC System is composted ADAM-rWBC(equipment) and ADAM-rWBC kit (reagent). This system is intended to be used for the qualitative determination of the residual white blood cell (leukocyte) count in human specimen.
It is used for the quantitative determination of the residual white blood cell (
It is used for the quantitative determination of the residual white blood cell (leukocyte) count in a human specimen using ADAM-rWBC.
The COVID-19 total Ab is designed for the qualitative and quantitative measureme
The COVID-19 total Ab is designed for the qualitative and quantitative measurement of anti-coronavirus IgG and IgM in human serum and plasma (Li-heparinized, EDTA,and citrate) by fluorescence immunoassay (FIA) using the FREND™ System.
FREND™ Blocking Reagent is provided in 15 tubes, the blocking reagent is buffer
FREND™ Blocking Reagent is provided in 15 tubes, the blocking reagent is buffer based containing constituents of human origin as well as purified chemicals. Preservatives and stabilizers have been added to maintain product integrity. The Blocking Reagent is provided in a dried solid state.
FREND™ TSH Linearity Kit is intended for use as an assayed linearity material fo
FREND™ TSH Linearity Kit is intended for use as an assayed linearity material for the thyroid stimulating hormone (TSH) on the FREND™ System. The Linearity Kit is for the FREND™ System only.FREND™ TSH Linearity Kit is provided at five levels to assist in the checking of analytical systems within the clinical range. The kit is horse serum-based containing constituents of human origin as well as purified chemicals. Preservatives and stabilizers have been added to maintain product integrity. The kit is a ready-to-use liquid requiring no reconstitution.
JJX
Single (Specified) Analyte Controls (Assayed And Unassayed)
FREND™ TSH Linearity Kit is intended for use as an assayed linearity material fo
FREND™ TSH Linearity Kit is intended for use as an assayed linearity material for the thyroid stimulating hormone (TSH) on the FREND™ System. The Linearity Kit is for the FREND™ System only.FREND™ TSH Linearity Kit is provided at five levels to assist in the checking of analytical systems within the clinical range. The kit is horse serum-based containing constituents of human origin as well as purified chemicals. Preservatives and stabilizers have been added to maintain product integrity. The kit is a ready-to-use liquid requiring no reconstitution.
JJX
Single (Specified) Analyte Controls (Assayed And Unassayed)
FREND™ Testosterone Linearity Kit is intended for use as an assayed linearity ma
FREND™ Testosterone Linearity Kit is intended for use as an assayed linearity material for the testosterone on the FREND™ System. The Linearity Kit is for the FREND™ System only.FREND™ Testosterone Linearity Kit is provided at five levels to assist in the checking of analytical systems within the clinical range. The kit is horse serum-based containing constituents of human origin as well as purified chemicals. Preservatives and stabilizers have been added to maintain product integrity. The kit is a ready-to-use liquid requiring no reconstitution
JJX
Single (Specified) Analyte Controls (Assayed And Unassayed)
FREND™ PSA Plus Linearity Kit is intended for use as an assayed linearity materi
FREND™ PSA Plus Linearity Kit is intended for use as an assayed linearity material for the prostate-specific antigen (PSA) on the FREND™ System. The Linearity kit is for the FREND™ System only.FREND™ PSA Plus Linearity Kit is provided at five levels to assist in the checking of analytical systems within the clinical range. The kit is horse serum-based containing constituents of human origin as well as purified chemicals. Preservatives and stabilizers have been added to maintain product integrity. The kit is a ready-to-use liquid requiring no reconstitution.
JJX
Single (Specified) Analyte Controls (Assayed And Unassayed)
FREND™ Free T4 Linearity Kit is intended for use as an assayed linearity materia
FREND™ Free T4 Linearity Kit is intended for use as an assayed linearity material for the free thyroxine (Free T4) on the FREND™ System. The Linearity Kit is for the FREND™ System only.FREND™ Free T4 Linearity Kit is provided at five levels to assist in the checking of analytical systems within the clinical range. The kit is horse serum-based containing constituents of human origin as well as purified chemicals. Preservatives and stabilizers have been added to maintain product integrity. The kit is a ready-to-use liquid requiring no reconstitution.
JJX
Single (Specified) Analyte Controls (Assayed And Unassayed)
It is used for the quantitiative determination of Prostate Specific Antigen(PSA)
It is used for the quantitiative determination of Prostate Specific Antigen(PSA) in human specimen using FREND System.
LTJ
Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers
It is used for the quantitative determination of free thyroxine(free t4) in huma
It is used for the quantitative determination of free thyroxine(free t4) in human specimen using FREND System.
It is used for the quantitative measurement of Total Testosterone in human serum
It is used for the quantitative measurement of Total Testosterone in human serum or heparinized, EDTA plasma sample.
CDZ
Radioimmunoassay, Testosterones And Dihydrotestosterone
It is used for the quantitative measurement of 25-hydroxy vitamin D and related
It is used for the quantitative measurement of 25-hydroxy vitamin D and related hydroxylated metabolites in humna serum and plasma.
It is used for the quantitative determination of free thyroxine(free t4) in huma
It is used for the quantitative determination of free thyroxine(free t4) in human specimen using FREND System.
It is used for the quantitiative determination of Prostate Specific Antigen(PSA)
It is used for the quantitiative determination of Prostate Specific Antigen(PSA) in human specimen using FREND System.
LTJ
Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers
The r-Control RBC and PLT consists of red blood cell (RBC) Low & RBC High proces
The r-Control RBC and PLT consists of red blood cell (RBC) Low & RBC High process controls and platelet (PLT) Low & PLT High process controls. It is intended for use with ADAM-rWBC Kit to monitor the process for enumeration of residual leukocytes in leukocyte reduced RBC and PLT products, including dilution, staining, instrument setup, and white blood cell (WBC) enumeration. For in vitro diagnostic use only.
The DHC-F0420 grid pattern is exactly the same as the Fuchs-Rosenthal. It consis
The DHC-F0420 grid pattern is exactly the same as the Fuchs-Rosenthal. It consists of 16 large squares orientated by triple lines, each measuring 1 x 1 mm, giving a total area 4 x 4 mm.
The DHC-F04 grid pattern is exactly the same as the Fuchs-Rosenthal. It consists
The DHC-F04 grid pattern is exactly the same as the Fuchs-Rosenthal. It consists of 16 large squares orientated by triple lines, each measuring 1 x 1 mm, giving a total area 4 x 4 mm.
The DHC-B0420 grid pattern is exactly same as the Burker. It consists of 9 large
The DHC-B0420 grid pattern is exactly same as the Burker. It consists of 9 large squares, each measuring 1 x 1 mm, and the depth of the chamber is 0.1 mm. Each square has a total volume of 0.1 mm3 or 10-4 cm3.
The DHC-B04 grid pattern is exactly same as the Burker. It consists of 9 large s
The DHC-B04 grid pattern is exactly same as the Burker. It consists of 9 large squares, each measuring 1 x 1 mm, and the depth of the chamber is 0.1 mm. Each square has a total volume of 0.1 mm3 or 10-4 cm3.
The DHC-N0420 grid pattern is exactly same as the Neubauer Improved. It consists
The DHC-N0420 grid pattern is exactly same as the Neubauer Improved. It consists of 9 large squares, each measuring 1 x 1 mm, and the depth of the chamber is 0.1 mm. Each square has a total volume of 0.1 mm3 or 10-4 cm3.
The DHC-N04 grid pattern is exactly same as the Neubauer Improved. It consists o
The DHC-N04 grid pattern is exactly same as the Neubauer Improved. It consists of 9 large squares, each measuring 1 x 1 mm, and the depth of the chamber is 0.1 mm. Each square has a total volume of 0.1 mm3 or 10-4 cm3.
The C-Chip is a disposable plastic chamber used for blood cell (Erythrocyte, Leu
The C-Chip is a disposable plastic chamber used for blood cell (Erythrocyte, Leukocyte) counting. It consists of surface-patterned two enclosed chambers with two ports for sample injection. The DHC-M01 grid pattern is exactly same as the Malassez. It consists of 25 large squares, each measuring 0.2 x 0.25 mm and the depth of the chamber is 0.2 mm. Each square has a total volume of 0.01 mm3 or 10-5 cm3.The large squares are subdivided into 20 small squares with an area of 0.0025 mm2.Cells per mL = average count per large square x dilution factor x 105 (dilution factor)
The C-Chip is a disposable plastic chamber used for blood cell (Erythrocyte, Leu
The C-Chip is a disposable plastic chamber used for blood cell (Erythrocyte, Leukocyte) counting. It consists of surface-patterned two enclosed chambers with two ports for sample injection. The DHC-F01 grid pattern is exactly the same as the Fuchs-Rosenthal. It consists of 16 large squares orientated by triple lines, each measuring 1 x 1 mm, giving a total area 4 x 4 mm.
The C-Chip is a disposable plastic chamber used for blood cell (Erythrocyte, Leu
The C-Chip is a disposable plastic chamber used for blood cell (Erythrocyte, Leukocyte) counting. It consists of surface-patterned two enclosed chambers with two ports for sample injection. The DHC-B02 grid pattern is exactly the same as the Burker-Turk. It consists of 9 large squares, each measuring 1 x 1 mm and the depth of the chamber is 0.1 mm. Each square has a total volume of 0.1 mm3 or 10-4 cm3.The large squares are subdivided into 16 group squares with 0.2 mm sides. In the central large square, each group is subdivided into 16 mini squares with 0.05 mm sides (=0.0025 mm2).
The C-Chip is a disposable plastic chamber used for blood cell (Erythrocyte, Leu
The C-Chip is a disposable plastic chamber used for blood cell (Erythrocyte, Leukocyte) counting. It consists of surface-patterned two enclosed chambers with two ports for sample injection. The DHC-B01 grid pattern is exactly the same as the Burker. It consists of 9 large squares, each measuring 1 x 1 mm, and the depth of the chamber is 0.1 mm. Each square has a total volume of 0.1 mm3 or 10-4 cm3.The large squares are subdivided into 16 group squares with 0.2 mm sides. The group squares correspond in size to the Neubauer grid but have no further subdivisions.
The C-Chip is a disposable plastic chamber used for blood cell (Erythrocyte, Leu
The C-Chip is a disposable plastic chamber used for blood cell (Erythrocyte, Leukocyte) counting. It consists of surface-patterned two enclosed chambers with two ports for sample injection. The DHC-N01 grid pattern is exactly same as the Neubauer Improved. It consists of 9 large squares, each measuring 1 x 1 mm, and the depth of the chamber is 0.1 mm. Each square has a total volume of 0.1 mm3 or 10-4 cm3 (Fig. 1). The central square is divided into 25 small squares with triple lines and four corner squares are divided into 16 small squares.
It is used for the quantitiative determination of Testosterone in human specimen
It is used for the quantitiative determination of Testosterone in human specimen using FREND System.
CDZ
Radioimmunoassay, Testosterones And Dihydrotestosterone
It is used for the quantitative determination of Thyroid Stimulating Hormone in
It is used for the quantitative determination of Thyroid Stimulating Hormone in human specimen using FREND System.
QuickProfile™ 2019-nCoV IgG/IgM Test Card is an immunochromatography based one s
QuickProfile™ 2019-nCoV IgG/IgM Test Card is an immunochromatography based one step in vitro test. It is designed for the rapid qualitative determination of IgG and IgM antibodies to the 2019 novel coronavirus (2019-nCoV, SARS-CoV-2) in human serum, plasma, or whole blood. QuickProfile™ 2019-nCoV IgG/IgM Test Card is a supplemental rapid screening tool for symptomatic or asymptomatic carriers of the virus.
The Access SARS-CoV-2 IgG II QC is intended for monitoring system performance of
The Access SARS-CoV-2 IgG II QC is intended for monitoring system performance of the Access SARS-CoV-2 IgG II assay using the Access Immunoassay Systems only.The Access SARS-CoV-2 IgG II QC are only for use under the Food and Drug Administration's Emergency Use Authorization.
The Access SARS-CoV-2 IgG II Calibrators are intended to calibrate the Access SA
The Access SARS-CoV-2 IgG II Calibrators are intended to calibrate the Access SARS-CoV-2 IgG II assay for the in vitro semi-quantitative and qualitative detection of SARS-CoV-2 IgG antibodies in human plasma (lithium heparin, dipotassium EDTA, tripotassium EDTA, and sodium citrate) for use on the Access Immunoassay Systems only.The Access SARS-CoV-2 IgG II calibrators are only for use under the Food and Drug Administration's Emergency Use Authorization.
The Access SARS-CoV-2 IgG II assay is a paramagnetic particle, chemiluminescent
The Access SARS-CoV-2 IgG II assay is a paramagnetic particle, chemiluminescent immunoassay intended for the semi-quantitative and qualitative detection of IgG antibodies to SARS-CoV-2 in human plasma (lithium heparin, dipotassium EDTA, tripotassium EDTA, and sodium citrate). The Access SARS-CoV-2 IgG II assay is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. At this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity. The Access SARS-CoV-2 IgG II should not be used to diagnose or exclude acute SARS-CoV-2 infection. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, that meet requirements to perform moderate or high complexity tests.The Access SARS-CoV-2 IgG II assay is only for use under the Food and Drug Administration's Emergency Use Authorization.
The Access SARS-CoV-2 IgG QC is intended for monitoring system performance of th
The Access SARS-CoV-2 IgG QC is intended for monitoring system performance of the Access SARS-CoV-2 IgG assay. The Access SARS-CoV-2 IgG QC is for use on the Access Family of Immunoassay Systems only.The Access SARS-CoV-2 IgG QC are only for use under the Food and Drug Administration's Emergency Use Authorization.
The Access SARS-CoV-2 IgG Calibrators are intended to calibrate the Access SARS-
The Access SARS-CoV-2 IgG Calibrators are intended to calibrate the Access SARS-CoV-2 IgG assay for the in vitro qualitative detection of SARS-CoV-2 IgG antibodies in human serum, serum separator tubes and plasma (lithium heparin, dipotassium EDTA, tripotassium EDTA, and sodium citrate) for use on the Access Family of Immunoassay Systems only. The Access SARS-CoV-2 IgG Calibrators are only for use under the Food and Drug Administration's Emergency Use Authorization.
The Access SARS-CoV-2 IgG assay is a paramagnetic particle, chemiluminescent imm
The Access SARS-CoV-2 IgG assay is a paramagnetic particle, chemiluminescent immunoassay intended for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum, serum separator tubes and plasma (lithium heparin, dipotassium EDTA, tripotassium EDTA, and sodium citrate). The Access SARS-CoV-2 IgG assay is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. At this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, that meet requirements to perform moderate or high complexity tests.The Access SARS-CoV-2 IgG assay is only for use under the Food and Drug Administration's Emergency Use Authorization.
The Access SARS-CoV-2 IgM QC is intended for monitoring system performance of th
The Access SARS-CoV-2 IgM QC is intended for monitoring system performance of the Access SARS-CoV-2 IgM assay. The Access SARS-CoV-2 IgM QC is for use on the Access Family of Immunoassay Systems only.The Access SARS-CoV-2 IgM QC are only for use under the Food and Drug Administration's Emergency Use Authorization.
The Access SARS-CoV-2 IgM Calibrators are intended to calibrate the Access SARS-
The Access SARS-CoV-2 IgM Calibrators are intended to calibrate the Access SARS-CoV-2 IgM assay for the in vitro qualitative detection of SARS-CoV-2 IgM antibodies in human serum, serum separator tubes and plasma (lithium heparin, dipotassium EDTA, tripotassium EDTA, sodium citrate) for use on the Access Family of Immunoassay Systems only.The Access SARS-CoV-2 IgM calibrators are only for use under the Food and Drug Administration's Emergency Use Authorization.
The Access SARS-CoV-2 IgM is a paramagnetic particle, chemiluminescent immunoass
The Access SARS-CoV-2 IgM is a paramagnetic particle, chemiluminescent immunoassay intended for the qualitative detection of IgM antibodies to SARS-CoV-2 in human serum, serum separator tubes and plasma (lithium heparin, dipotassium EDTA, tripotassium EDTA, sodium citrate). The Access SARS-CoV-2 IgM is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. At this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity. The Access SARS-CoV-2 IgM should not be used to diagnose acute SARS-CoV-2 infection. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, that meet requirements to perform moderate or high complexity tests.The Access SARS-CoV-2 IgM assay is only for use under the Food and Drug Administration's Emergency Use Authorization.